SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-020346
Filing Date
2021-08-18
Accepted
2021-08-18 07:30:32
Documents
14
Period of Report
2021-08-18
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20210811_8k.htm   iXBRL 8-K 20374
6 moleculinlogoresizedclear.jpg GRAPHIC 19339
  Complete submission text file 0001437749-21-020346.txt   205598

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20210818.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20210818_def.xml EX-101.DEF 11804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20210818_lab.xml EX-101.LAB 15848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20210818_pre.xml EX-101.PRE 12019
7 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20210811_8k_htm.xml XML 2650
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 211185014
SIC: 2834 Pharmaceutical Preparations